New Assessment Identifies the High-Risk Functions Within Pharma That Are Least Prepared for Challenges Ahead

Sales Rep Training, Forecasting, Competitive Intelligence, Patient Support Services, and KOL Relationship Management among the Functions within the Pharmaceutical Commercial Model Most in Need of Change During and Post-Pandemic

April 28, 2020 13:03 UTC

Sales Rep Training, Forecasting, Competitive Intelligence, Patient Support Services, and KOL Relationship Management among the Functions within the Pharmaceutical Commercial Model Most in Need of Change During and Post-Pandemic

WALTHAM, Mass.--(BUSINESS WIRE)-- Trinity Life Sciences, a leader in global life sciences solutions, announced today the availability of a new TGaS benchmarking assessment that identifies the high-risk functions within pharma that are least prepared for challenges generated by the COVID-19 pandemic.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200428005567/en/

The dashboard reflects the impact of COVID-19 on life science companies' commercial capabilities. (Graphic: Business Wire)

The dashboard reflects the impact of COVID-19 on life science companies’ commercial capabilities. (Graphic: Business Wire)

Sales rep training, forecasting, competitive intelligence, patient support services and KOL relationship management are among the highest risk functions that need to consider significant evolution to adjust to a current and post-pandemic world.

“The COVID-19 crisis has all of us engaged with the U.S. healthcare system thinking about how the future may look different than our collective past,” said Gary McWalters, President of TGaS Advisors, a Division within Trinity. “With forward-looking ideas in mind, TGaS has considered the most likely changes within the pharmaceutical commercial model and assessed which commercial operations functional areas are most likely to be least prepared from a capabilities perspective for the challenges that lie ahead.”

The dashboard can be viewed: Impact of COVID-19 on Commercial Capabilities by Functional Area.

About Trinity Life Sciences

Trinity Life Sciences is a trusted strategic partner, providing evidence-based solutions for the life sciences. With over 20 years of experience, Trinity is committed to solving clients’ most challenging problems through exceptional levels of service, powerful tools, and data-driven insights. Trinity’s range of products and solutions includes industry-leading benchmarking solutions, powered by TGaS Advisors. To learn more about how Trinity is elevating life sciences and driving evidence to action, visit trinitylifesciences.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20200428005567/en/

Contacts

For more information:
Elizabeth Marshall
Trinity Life Sciences
781-577-6376
emarshall@trinitylifesciences.com

Source: Trinity Life Sciences

Smart Multimedia Gallery

The dashboard reflects the impact of COVID-19 on life science companies’ commercial capabilities. (Graphic: Business Wire)

Powered by Business Wire

View this news release and multimedia online at:
http://www.businesswire.com/news/home/20200428005567/en

MORE ON THIS TOPIC